Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-5c6d5d7d68-wtssw Total loading time: 0 Render date: 2024-08-08T08:54:13.588Z Has data issue: false hasContentIssue false

Chapter 6 - Clinical Management of Mitochondrial Diseases

from Section 1 - Introduction to Mitochondrial Medicine

Published online by Cambridge University Press:  28 April 2018

By
Rita Horvath
Edited by
Patrick F. Chinnery  and
Michael J. Keogh
Patrick F. Chinnery
Affiliation:
University of Cambridge
Michael J. Keogh
Affiliation:
University of Newcastle upon Tyne
Get access

Summary

A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Chapter
Information
Clinical Mitochondrial Medicine , pp. 59 - 68
Publisher: Cambridge University Press
Print publication year: 2018

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Nightingale, H, Pfeffer, G, Bargiela, D, et al. Emerging therapies for mitochondrial disorders. Brain 2016;139(Pt 6):1633–1648.CrossRefGoogle ScholarPubMed
Foley, AR, Menezes, MP, Pandraud, A, et al. Treatable childhood neuronopathy caused by mutations in riboflavin transporter RFVT2. Brain 2014;137(Pt 1):44–56.CrossRefGoogle ScholarPubMed
Horvath, R. Update on clinical aspects and treatment of selected vitamin-responsive disorders II (riboflavin and CoQ 10). J Inherit Metab Dis. 2012;35(4):679–687.CrossRefGoogle ScholarPubMed
Olsen, RK, Koňaříková, E, Giancaspero, TA, et al. Riboflavin-responsive and non-responsive mutations in FAD synthase cause multiple Acyl-CoA Dehydrogenase and combined respiratory-chain deficiency. Am J Hum Genet 2016;98(6):1130–1145.Google Scholar
Schiff, M, Haberberger, B, Xia, C, et al. Complex I assembly function and fatty acid oxidation enzyme activity of ACAD9 both contribute to disease severity in ACAD9 deficiency. Hum Mol Genet 2015;24(11):3238–3247.Google Scholar
Alfadhel, M, Almuntashri, M, Jadah, RH, et al. Biotin-responsive basal ganglia disease should be renamed biotin-thiamine-responsive basal ganglia disease: A retrospective review of the clinical, radiological and molecular findings of 18 new cases. Orphanet J Rare Dis. 2013;8:83.CrossRefGoogle ScholarPubMed
Bergmann, AK, Sahai, I, Falcone, JF, et al. Thiamine-responsive megaloblastic anemia: Identification of novel compound heterozygotes and mutation update. J Pediatr 2009;155(6):888–892.e1.CrossRefGoogle ScholarPubMed
Emmanuele, V, López, LC, Berardo, A, et al. Heterogeneity of coenzyme Q10 deficiency: Patient study and literature review. Arch Neurol 2012;69(8):978–983.CrossRefGoogle ScholarPubMed
Brea-Calvo, G, Haack, TB, Karall, D, et al. COQ4 mutations cause a broad spectrum of mitochondrial disorders associated with CoQ10 deficiency. Am J Hum Genet 2015;96(2):309–317.CrossRefGoogle Scholar
Parikh, S, Goldstein, A, Koenig, MK, et al. Diagnosis and management of mitochondrial disease: A consensus statement from the Mitochondrial Medicine Society. Genet Med 2015;17(9):689–701.Google Scholar
Ahola, S, Auranen, M, Isohanni, P, et al. Modified Atkins diet induces subacute selective ragged-red-fiber lysis in mitochondrial myopathy patients. EMBO Mol Med 2016;8(11):1234–1247.CrossRefGoogle ScholarPubMed
Prasad, C, Rupar, T, Prasad, AN. Pyruvate dehydrogenase deficiency and epilepsy. Brain Dev 2011;33(10):856–865.CrossRefGoogle ScholarPubMed
Yu-Wai-Man, P, Votruba, M, Moore, AT, Chinnery, PF. Treatment strategies for inherited optic neuropathies: Past, present and future. Eye (Lond) 2014;28(5):521–537.CrossRefGoogle ScholarPubMed
Pfeffer, G, Majamaa, K, Turnbull, DM, et al. Treatment for mitochondrial disorders. Cochrane Database Syst Rev 2012;4:CD004426.Google Scholar
Bates, MG, Newman, JH, Jakovljevic, DG, et al. Defining cardiac adaptations and safety of endurance training in patients with m.3243A>G-related mitochondrial disease. Int J Cardiol. 2013;168(4):3599–3608.CrossRefGoogle ScholarPubMed
Grabhorn, E, Tsiakas, K, Herden, U, et al. Long-term outcomes after liver transplantation for deoxyguanosine kinase deficiency: A single-center experience and a review of the literature. Liver Transpl 2014;20(4):464–472.CrossRefGoogle Scholar
Hynynen, J, Komulainen, T, Tukiainen, E, et al. Acute liver failure after valproate exposure in patients with POLG1 mutations and the prognosis after liver transplantation. Liver Transpl 2014;20(11):1402–1412.Google Scholar
De Giorgio, R, Pironi, L, Rinaldi, R, et al. Liver transplantation for mitochondrial neurogastrointestinal encephalomyopathy. Ann Neurol 2016;80(3):448–455.CrossRefGoogle ScholarPubMed
Dionisi-Vici, C, Diodato, D, Torre, G, et al. Liver transplant in ethylmalonic encephalopathy: A new treatment for an otherwise fatal disease. Brain 2016;139(Pt 4):1045–1051.Google Scholar
Halter, J, Schüpbach, WM, Casali, C, et al. Allogeneic hematopoietic SCT as treatment option for patients with mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): A consensus conference proposal for a standardized approach. Bone Marrow Transplant 2011;46(3):330–337.Google Scholar
Clarke, SL, Bowron, A, Gonzalez, IL, et al. Barth syndrome. Orphanet J Rare Dis 2013;8:23.CrossRefGoogle ScholarPubMed
Gorman, GS, Grady, JP, Ng, Y, et al. Mitochondrial donation – how many women could benefit? N Engl J Med 2015;372(9):885–887.CrossRefGoogle ScholarPubMed
Herbert, M, Turnbull, D. Mitochondrial donation – clearing the final regulatory hurdle in the United Kingdom. N Engl J Med 2017;376(2):171–173.Google Scholar
Torres-Torronteras, J, Viscomi, C, Cabrera-Pérez, R, et al. Gene therapy using a liver-targeted AAV vector restores nucleoside and nucleotide homeostasis in a murine model of MNGIE. Mol Ther 2014;22(5):901–907.Google Scholar
Garone, C, Garcia-Diaz, B, Emmanuele, V, et al. Deoxypyrimidine monophosphate bypass therapy for thymidine kinase 2 deficiency. EMBO Mol Med 2014;6(8):1016–1027.CrossRefGoogle ScholarPubMed
Kanabus, M, Heales, SJ, Rahman, S. Development of pharmacological strategies for mitochondrial disorders. Br J Pharmacol 2014;171(8):1798–1817.Google Scholar
Pfeffer, G, Horvath, R, Klopstock, T, et al. New treatments for mitochondrial disease – no time to drop our standards. Nat Rev Neurol 2013;9(8):474–481.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×